AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 94 filers reported holding AVANIR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $15,090,000 | +58.3% | 2,675,514 | +3.0% | 0.00% | +33.3% |
| Q1 2014 | $9,530,000 | +0.9% | 2,596,734 | -7.6% | 0.00% | 0.0% |
| Q4 2013 | $9,441,000 | -51.1% | 2,809,774 | -38.4% | 0.00% | -50.0% |
| Q3 2013 | $19,325,000 | -57.0% | 4,557,810 | -53.3% | 0.01% | -60.0% |
| Q2 2013 | $44,935,000 | – | 9,768,545 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JAY JEFFREY R | 258,600 | $1,190,000 | 0.94% |
| BVF INC/IL | 1,006,053 | $4,628,000 | 0.90% |
| Artal Group S.A. | 2,750,000 | $12,650,000 | 0.40% |
| Baker Brothers Advisors | 3,578,591 | $16,462,000 | 0.33% |
| EAM Investors, LLC | 237,017 | $1,090,000 | 0.24% |
| Opus Trading Fund LLC | 23,888 | $110,000 | 0.21% |
| FORTALEZA ASSET MANAGEMENT INC/ | 61,795 | $284,000 | 0.16% |
| CR Intrinsic Investors, LLC | 898,538 | $4,133,000 | 0.14% |
| TimesSquare Capital Management, LLC | 4,261,478 | $19,603,000 | 0.12% |
| Lyons Wealth Management, LLC. | 25,340 | $116,000 | 0.12% |